GlassScriptPhysician profile
John G Adams
NPI 1710981444
$3,268.17
in general payments reported to CMS, 2019-2025
7 companies · $1,826 in 2025
The $1,826 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2021: $15.39 · 2022: $186 · 2023: $35.00 · 2025: $1,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,826 · Food and Beverage: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,825.64 |
| Food and Beverage | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,825.64 | 2025 | Venacure Evlt |
| Silk Road Medical, INC. | $924.91 | 2019 | |
| W. L. Gore & Associates, INC. | $448.05 | 2019-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Sun Pharmaceutical Industries INC. | $20.26 | 2022 | |
| Ethicon US, LLC | $19.19 | 2022 | |
| Abbvie INC. | $15.39 | 2021 | |
| Boston Scientific Corporation | $14.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.